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A CAK capable of phosphorylating and activatingFrance
Cdc2 and Cdk2 has been isolated from Xenopus, star-
fish, and mammalian cells (Fesquet et al., 1993; Poon
et al., 1993; Solomon et al., 1993; Darbon et al., 1994;
Summary Fisher and Morgan, 1994; Labbe´ et al., 1994; Wu et al.,
1994). The catalytic subunit of this kinase was identified
Cyclin-dependent protein kinases (Cdks) play key as p40-MO15 and later renamed cdk7 because it was
roles in regulating cell division and gene expression. found to be associated with a cyclin-like activating sub-
Most Cdks require binding of a cyclin and phosphory- unit called cyclin H (Fisher and Morgan, 1994; Ma¨kela¨
lation by a Cdk-activating kinase (CAK) to be active. et al., 1994) as well as an assembly factor called MAT1
We report the identification of Civ1 (CAK in vivo), a (Devault et al., 1995; Fisher et al., 1995; Tassan et al.,
novel CAK activity in S. cerevisiae. Civ1 is most similar 1995; Yee et al., 1995). Remarkably, cdk7–cyclin H was
in sequence to the Cdks, but unlike them is active as also found to be a component of the transcription factor
a monomer and may thus be the founding member of complex called TFIIH (Roy et al., 1994; Serizawa et al.,
a novel family of kinases. Civ1 binds tightly to and 1995; Shiekhattar et al., 1995). TFIIH is required for the
phosphorylates Cdc28, thereby allowing its subse- basal transcription of genes by RNA polymerase II, and
quent activation by the binding of a cyclin. The CIV1 the cdk7–cyclin H kinase can phosphorylate the re-
gene is essential for yeast cell viability, and Cdc28 peated sequences of the carboxy-terminal domain
phosphorylation and activity are conditionally inhib- (CTD) of the large subunit of this polymerase. This unex-
ited in a civ1-4 temperature-sensitive mutant. Civ1 is pected activity of CAK could be an indication that cdk7–
the only CAK for which there are genetic data indicat- cyclin H coordinately regulates gene expression and cell
ing that its activity is physiologically relevant in vivo. cycle progression. However, it cannot be ruled out that
the biochemical specificity of cdk7–cyclin H is more
promiscuous in vitro than was initially anticipated andIntroduction
that its true biological function in vivo is more limited.
Given the high degree of functional conservation inCyclin-dependent protein kinases (Cdks) were first iden-
eukaryotic cell cycle regulators, the identification oftified as key regulators of the eukaryotic cell division
cdk7–cyclin H homologs in more genetically tractablecycle (Nurse, 1990; Murray and Hunt, 1993). Cdc28 of
organisms should allow a test of the in vivo functionsSaccharomyces cerevisiae and Cdc2 of Schizosacchar-
of this kinase. Apparent homologs of cdk7–cyclin H haveomyces pombe are the founding members of this family
indeed been identified in the budding and fission yeasts.and are required at both the G1/S and G2/M transitions
The Mop1(Crk1)–Mcs2 kinase of S. pombe is very similarof the cell cycle (Forsburg and Nurse, 1991). In higher
in sequence to cdk7–cyclin H and has been shown ineukaryotes, the multiple functions of the yeast Cdc2/
vitro to have both CAK and CTD kinase activity (BuckCdc28 kinase are carried out by several related Cdks
et al., 1995; Damagnez et al., 1995). The study of mutant(Dore´e and Galas, 1994; Pines, 1994; Nigg, 1995). More
forms of this kinase will be decisive in deciding whetherrecently discovered members of the Cdk family have
it participates in Cdc2 phosphorylation and activationalso been implicated in regulating gene expression and
or TFIIH activity (or both) in vivo in the fission yeast. InDNA repair (Poon and Hunter, 1995b). Cdks require for
S. cerevisiae, Kin28–Ccl1 is the apparent homolog of
their activation, in addition to the binding of a cyclin
cdk7–cyclin H in terms of sequence similarity and by its
molecule, their phosphorylation on a conserved threo-
presence in budding yeast TFIIH (Simon et al., 1986;
nine in a region called the T-loop (Morgan, 1995). The
Valay et al., 1993; Feaver et al., 1994; Cismowski et al.,
mechanism of this activation is not yet clear. Based on
1995; Valay et al., 1995). Kin28 immunoprecipitated from
the crystal structure of Cdk2 bound to a fragment of
whole-cell extracts shows CTD kinase activity, but un-
cyclin A, phosphorylation of Cdk2 Thr-160 is postulated
like Mop1(Crk1) has no CAK activity (Cismowski et al.,
1995). Interestingly, kin28-ts mutants (Cismowski et al.,
1995; Valay et al., 1995) and ccl1-ts mutants (Valay et‡Present address: Laboratoire de Ge´ne´tique Mole´culaire des
al., 1996) are clearly defective at the restrictive tempera-Plantes, UMR Centre National de la Recherche Scientifique-UJF
ture in the transcription of class II genes, and the large5575, Universite´ Joseph Fourier, CERMO, BP53, F-38041 Grenoble
Cedex 09, France. subunit of RNA polymerase II is hypophosphorylated in
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these mutants. On the other hand, phosphorylation of
Cdc28, the functional homolog inbudding yeast of Cdc2,
was unaffected in a kin28-ts mutant (Cismowski et al.,
1995). These results demonstrate that the Kin28–Ccl1
kinase has an essential in vivo role in gene expression.
In contrast, CAK must be coded for by a gene other
than KIN28 in S. cerevisiae. It might have been antici-
pated that the budding yeast CAK would be another
cdk7-like kinase, but we show in this paper that it is in
fact a distinct type of protein kinase.
Results
A Yeast CAK Copurifies with Cdc28
Cdc28 is a Cdk of S. cerevisiae whose action is required
at several points of the cell division cycle (Nasmyth,
1993). We are interested in reconstituting in vitro Cdc28–
cyclin kinase complexes in order to study the activation
and inactivation of this key cell cycle regulator. We
added a tag of six tandem histidines (His6) to the car-
boxyl terminus of Cdc28 to facilitate its biochemical
purification. The tagged protein is functional in vivo, as
seen by its ability to complement a cdc28 deletion mu-
tant (unpublished data). As we were unsuccessful in
our attempts to obtain active Cdc28–His6 protein from
Escherichia coli, we decided to overexpress and purify
Cdc28 from yeast. The Cdc28–His6 coding sequence
was expressed from the strong GAL1 promoter on a
multicopy plasmid. After ammonium sulfate precipita-
tion and purification on a nickel–nitrilotriacetic acid (Ni–
NTA)–agarose column, Cdc28–His6 was found to be the
major protein in the fractions eluted with imidazole (Fig-
ure 1A, lane 4). Our partially purified Cdc28–His6 from
yeast had no histone H1 kinase activity in vitro (Figure
1B, lane 1). Remarkably, the simple addition of human Figure 1. Cdc28–His6 Is Phosphorylated by a Copurifying CAK on
cyclin A activated the kinase (Figure 1B, lane 2). This Thr-169 in Partially Purified Preparations from Yeast
result was surprising in that the activation of most Cdks (A) Cdc28–His6 was purified by Ni–NTA–agarose chromatography
requires both the binding of a cyclin molecule and the from strain CMY826/pDYM1 as described in Experimental Proce-
phosphorylation of the Cdk on a specific threonine resi- dures. Aliquots of the crude protein extract loaded onto the column
(input), the flowthrough fraction (FT), the 20 mM imidazole washdue (Thr-169 of Cdc28) in a region of the kinase called
fraction (wash), and the 250 mM elution fraction (eluate) were elec-the T-loop. We thus examined whether Cdc28–His6 is
trophoresed on an SDS–10% polyacrylamide gel, and proteins werephosphorylated in vitro. Indeed, we observed that the
stained with Coomassie blue.addition of ATP leads to the phosphorylation of Cdc28–
(B) Cdc28–His6 kinase activity requires the addition of a cyclin. TheHis6 whether or not cyclin A is present (Figure 1C, lanes histone H1 kinase activity of 100 ng of Cdc28–His6 (purified from
1 and 2). This phosphorylation could not be attributed yeast by Ni–NTA–agarose chromatography) was assayed in the ab-
to an autophosphorylation, because it was still seen sence (lane 1) or the presence (lane 2) of 200 ng of human cyclin A
purified from E. coli (see Experimental Procedures). 32P-phosphory-when a Cdc28(K40R)–His6 mutant was purified from
lated histone H1 was visualized after SDS–polyacrylamide gel elec-yeast (Figure 1C, lane 3). Mutation of the conserved Lys-
trophoresis (SDS–PAGE) and autoradiography.40 to arginine inactivated Cdc28 function in vivo as well
(C) Cdc28–His6 is phosphorylated on Thr-169 in the presence oras its histone H1 kinase activity in vitro (unpublished
absence of cyclin by a copurifying CAK activity. We incubated 200
data). Thus, Cdc28–His6 phosphorylation in vitro was ng of Ni–NTA–agarose-purified Cdc28–His6 (lanes 1 and 2),
due to a distinct copurifying protein kinase. This phos- Cdc28(K40R)–His6 (lane 3), or Cdc28(T169A)–His6 (lane 4) with [g-
phorylation apparently occurred at the activating Thr- 32P]ATP as described in Experimental Procedures. The phosphoryla-
tion reaction shown in lane 1 contained in addition 500 ng of human169 of Cdc28, in that it was not seen for a purified
cyclin A. Cyclin A is phosphorylated by Cdc28–His6 in this reaction.Cdc28(T169A)–His6 mutant (Figure 1C, lane 4). Phos-
Phosphorylated proteins were visualized by SDS–PAGE and autora-phorylated Cdc28–His6 was inactive as a histone H1
diography. Relative 32P incorporation in lanes 1 and 2 are not compa-kinase, but it could beactivated by the addition of human
rable because these phosphorylation reactions were performed at
cyclin A, as noted above (Figure 1B). Thus, we conclude different times. However, we have reproducibly observed a hyper-
that an endogenous Cdc28-activating kinase (CAK) co- phosphorylation of the K40R mutant (lane 3) relative to wild-type
purified with our Cdc28–His6 preparation from yeast. Cdc28 (lane 2) under these same reaction conditions. It is not known
why the K40R mutant is phosphorylated to higher levels than the
wild-type Cdc28.CIV1 Encodes the Yeast CAK
We sought to identify the yeast CAK. The p40MO15/cdk7–
cyclin H kinase has been identified as a CAK from higher
In Vivo CAK
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eukaryotes (for review see Solomon, 1994). The appar- We obtained further evidence that Civ1 is necessary
ent homolog (in terms of sequence similarity and by its for Cdc28–His6 phosphorylation and activation in vitro
presence in TFIIH) of the cdk7–cyclin H kinase in S. by taking advantage of a preexisting civ1 mutant. This
cerevisiae is the Kin28–Ccl1 kinase (Valay et al., 1993, mutant was isolated in a screen for mutations that are
1995, 1996; Feaver et al., 1994; Cismowski et al., 1995). synthetically lethal when combined with the kin28-ts3
CAK activity was unaffected when we purified Cdc28– mutation at the otherwise permissive temperature of
His6 from kin28-ts3 (Valay et al., 1995) or ccl1-ts4 (Valay 268C (Valay et al., 1995). The mutant was provisionally
et al., 1996) mutants, and we could not detect Kin28 in named mca28-782, and in accord with our revised no-
our Cdc28–His6 preparations with anti-Kin28 antibodies menclature we will henceforth call it civ1-1. Cdc28–His6
(unpublished data). These results agree with previous expressed in the civ1-1 mutant at 248C was purified and
work indicating that Kin28 is devoid of CAK activity (Cis- tested for in vitro phosphorylation. In contrast with the
mowski et al., 1995). Cdc28–His6 purified from the wild type, Cdc28–His6 puri-
We estimated the size of the yeast CAK by passing fied from civ1-1 was not phosphorylated when incu-
our Cdc28–His6 preparation over a Superdex 75 sizing bated with ATP in vitro at 248C, 308C, or 378C (Figure 3A).
column (see Experimental Procedures). CAK activity Moreover, the histone H1 kinase activity of Cdc28–His6
eluted from this column with a peak at approximately purified from civ1-1 could not be activated by the addi-
45 kDa. The yeast genome contains a relatively small tion of cyclin A (Figure 3B, lane 2). Cdc28–His6 phosphor-
number of genes coding for protein kinases of this size. ylation and activation could be reconstituted in vitro by
We had previously isolated one such gene as a dosage- mixing Cdc28–His6 purified from civ1-1 with a prepara-
dependent suppressor of kin28-ts mutations, which we tion of the Cdc28(T169A)–His6 mutant purified from a
provisionally called MCA28 (J.-G. V.’s wife is named wild-type strain expressing Gal4–Civ1 (Figures 3A, lane
Monica) (Valay, 1994; Valay et al., 1995). We now pro- 9, and 3B, lane 5). Thus, Cdc28–His6 purified from the
pose CIV1 (CAK in vivo) as the name for this gene based civ1-1 mutant contains no functional CAK, but this activ-
on its demonstrated physiological function (see below). ity can be provided by the Gal4–Civ1 that copurifies with
CIV1 encodes a predicted 42 kDa protein kinase (Figure the nonphosphorylatable Cdc28(T169A)–His6 mutant.2A). Civ1 has the closest overall similarity to the Cdc2 We noticed that phosphorylation of Cdc28–His6 byfamily of protein kinases, but differs from this family copurifying Civ1 occurred to the same extent when the
in several key aspects and thus may be the founding
kinase reaction was performed for 15 min at 248C, 308C,
member of a novel protein kinase family. Strikingly, Civ1
or 378C (Figure 3A, lanes 2, 4, and 6). This equivalent
does not contain the conserved glycine-rich motif
phosphorylation could not be accounted for by a limita-
GxGx(Y/F)GxV that is found in a loop that forms part of
tion of substrate, because the addition to the reactionthe ATP-binding site of most protein kinases (Bosse-
of a saturating quantity of His6–Civ1 (purified from yeastmeyer, 1994). In fact, Civ1 and Vps15, a yeast kinase
as described below), increased Cdc28–His6 phosphory-involved in protein sorting to the vacuole (Herman et al.,
lation 40-fold (Figure 3C). To examine further these reac-1991), are to our knowledge the only reported protein
tion kinetics, we carried out time courses of Cdc28–His6kinases to be missing all three glycines in this region.
phosphorylation by His6–Civ1 under conditions of sub-Civ1 also containsseveral insertions of 5–29 aminoacids
strate excess. These experiments showed that the initialbetween conserved elements of secondary structure
phosphorylation of Cdc28 by Civ1 was extremely rapid,found within the Cdk family (Figure 2A). Finally, unlike
but that further cycles of phosphorylation occurredthe Cdks, Civ1 can function as a monomer (see below).
slowly (Figure 3D). Hence, Civ1 apparently dissociatesCIV1 is an essential gene (see Experimental Proce-
only slowly from Cdc28 after phosphorylating it. Pre-dures). Spores containing a civ1::LEU2 disruption germi-
formation of a Cdc28–cyclin A complex increased thenate and divide several times before arresting cell divi-
rate of Cdc28 phosphorylation slightly, but recycling ofsion. Cells depleted of Civ1 have a filamentous cell
Civ1 was still limited (Figure 3D). Thus, turnover of Civ1phenotype indicative of a cell division arrest accompa-
is limited in our in vitro reaction conditions, perhapsnied by a continued polarized cell growth (Figure 2B).
because of a strong interaction between Civ1 andWe first examined whether CIV1 could code for the
Cdc28.yeast CAK by purifying Cdc28–His6 from a cell in which
Further evidence indicating that Civ1 and Cdc28 phys-we had coexpressed a Gal4–Civ1 fusion protein from
ically interact was obtained by coimmunoprecipitationthe strong ADHI promoter. Gal4–Civ1 copurified with
experiments from crude protein extracts of wild-typeCdc28–His6 upon elution from a Ni–NTA–agarose col-
cells. Immunoprecipitation of Cdc28 from whole-cellumn (unpublished data), suggesting that the two kinases
protein extracts with polyclonal anti-Cdc28 antibodieswere physically associated. Furthermore, Cdc28–His6
led to the coprecipitation of Civ1 (Figure 4A, lane 2).was more highly phosphorylated in vitro when purified
Likewise, precipitation of Civ1 with polyclonal anti-Civ1from a strain in which Gal4–Civ1 was coexpressed (Fig-
antibodies led to the coprecipitation of Cdc28 (Figureure 3A, lane 7) compared with the same strain express-
ing only the normal levels of Civ1 (Figure 3A, lane 6). 4B, lane 3).
We interpreted these results to indicate that Gal4–Civ1
can copurify with Cdc28–His6 and phosphorylate it in
Monomeric Civ1 Can Phosphorylate and Activatevitro. This in vitro phosphorylation was abolished when
GST–Cdk2 and Cdc28–His6Gal4–Civ1 was copurified with a Cdc28(T169A)–His6 mu-
The preceding results indicated that Civ1 was necessarytant (Figure 3A, lane 8), thereby indicating that the phos-
for CAK activity in vitro, but did not indicate whether itphorylation likely occurred on the activating Thr-169 of
Cdc28. was sufficient. We expressed a histidine-tagged version
Cell
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Figure 2. The Essential Civ1 Kinase May Be the Founding Member
of a Novel Class of Protein Kinases with Similarity to the Cdk Family
(A) Multiple alignments of Civ1 versus Cdks. In the first row, k indi-
cates a residue conserved in most protein kinases, and bold k indi-
cates a residue conserved in most kinases and in all the sequences
used for the alignment. In the second row, a black dot indicates
a residue often found in the Cdk family, an open circle indicates a
residue always found in the Cdk family, and a plus indicates a
residue conserved in Civ1 and the Cdk family. In the bottom row,
secondary structure of human Cdk2, a represents a helix and b
represents b sheet. The numbers in parentheses are the number of
amino acids in the divergent N- or C-terminal extensions of some
kinases that were not shown in this alignment. Additional kinase
sequences were used for the alignment (see Experimental Proce-
dures), which explains why some residues seemingly strictly con-
served above are indicated as mostly conserved residues. Civ1 and
Cdc28 share 25% identity, and 27 of the 45 residues conserved in
the Cdk family are also conserved in Civ1.
(B) CIV1 is an essential gene. Shown is the terminal phenotype of
nonviable civ1::LEU2haploid spores (see Experimental Procedures).
of Civ1 to high levels in yeast from the GAL1 promoter as a sharp peak of highly purified protein at 43 kDa
(Figure 5B), indicating that it was monomeric underon a multicopy plasmid. His6–Civ1 was the major protein
that was found in the fraction from a Ni–NTA–agarose these conditions. CAK activity as measured by phos-
phorylation of glutathione S-transferase (GST)–Cdk2column that was specifically eluted with 250 mM imidaz-
ole (Figure 5A). This preparation was active as a CAK, (Figure 5B) or Cdc28–His6 (unpublished data) was also
centered at this protein peak. The nearly homogeneousand it was further fractionated by passage on a Super-
dex 75 sizing column. Civ1–His6 eluted from this column Civ1 in the peak fraction 13 activated GST–Cdk2 or
In Vivo CAK
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Figure 3. Cdc28–His6 Phosphorylation and
Activation In Vitro Is Dependent on a Wild-
Type Civ1 Kinase and Kinetics of Cdc28
Phosphorylation by Civ1
(A) Phosphorylation of Cdc28–His6. In lanes
1–6, Cdc28–His6 purified on Ni–NTA–agarose
as described in Experimental Procedures
from CMY826 CIV11/pDYM1 (lanes 2, 4, and
6) and GF330-1C civ1-1/pDYM1 (lanes 1, 3,
and 5) was tested for phosphorylation of
Cdc28–His6 by a possibly copurifying CAK at
248C (lanes 1 and 2), 378C (lanes 3 and 4),
and 308C (lanes 5 and 6). In lanes 7 and 8,
Ni–NTA–agarose-purified fractions of Cdc28–
His6 from YJY88 (Gal4–Civ1, Cdc28–His6; lane
7) and YJY95 (Gal4–Civ1, Cdc28[T169A]–His6;
lane 8) were tested for phosphorylation of
Cdc28–His6 at 308C by the copurifying CAK.
In lane 9, in vitro complementation: Ni–NTA–
agarose-purified Cdc28–His6 from GF312-
17C civ1-1/pDYM1 and YJY95 CIV11 (Gal4–
Civ1, Cdc28[T169A]–His6) were mixed in
equal amounts and tested for phosphoryla-
tion of Cdc28–His6 at 308C. We used 100 ng
of Cdc28–His6 or Cdc28(T169A)–His6 for each
test.
(B) Activation of Cdc28–His6. The ability
of Ni–NTA–agarose-purified Cdc28–His6 to
phosphorylate histone H1 after addition of
cyclin A was assessed at 308C as described
in Experimental Procedures. Each assay contained 100 ng of Cdc28–His6 or Cdc28 (T169A)–His6 purified from yeast and 500 ng of human
cyclin A purified from E. coli. Lane 1, Cdc28–His6 purified from CIV11 (CMY826); lane 2, Cdc28–His6 purified from civ1-1 (GF330-1C); lane 3,
Cdc28(T169A)–His6 purified from a Gal4–Civ1 overexpressing strain (YJY95); lane 4, Cdc28–His6 purified from the Gal4–Civ1 overexpressing
strain (YJY88); lane 5 corresponds to lane 9 in (A): Cdc28–His6 purified from the civ1-1 strain GF312-17C is activated by Gal4–Civ1 copurified
with Cdc28(T169A)–His6 from strain YJY95.
(C) Substrate Cdc28–His6 is in excess with regard to copurifying Civ1. We incubated 100 ng of Cdc28–His6 purified from the strain CMY826/
pDYM1 as in (A), lanes 2, 4, and 6, with [g-32P]ATP in the absence (lane 1) or the presence (lane 2) of 300 ng of Ni–NTA-purified His6–Civ1 at
308C for 15 min. Relative incorporation of 32P onto Cdc28–His6 in lane 1 was 40-fold less than that in lane 2, and hence cannot be seen in this
figure.
(D) Kinetics of Cdc28–His6 phosphorylation by His6–Civ1 in conditions of excess substrate. We used 100 ng of Cdc28–His6 purified from GF330-
1C civ1-1/pDYM1, in the presence or absence of 200 ng of cyclin A, as substrate in a phosphorylation reaction with 0.6 ng of Ni–NTA-purified
His6–Civ1. His6–Civ1 was added to the reaction mixes on ice, and aliquots were then distributed into separate tubes on ice. One tube was
immediately placed in liquid nitrogen (0 min) and the other tubes were transferred to 308C for the indicated times before freezing in liquid
nitrogen. At the end of the time course, SDS sample buffer was added to the frozen samples, and these were boiled for 3 min. [32P]Cdc28
levels were determined by SDS–PAGE and PhosphorImager analysis. 32P incorporation is shown as relative PhosporImager (P.I.) units.
Cdc28–His6 in the presence of cyclin A, and this activa- of Civ1 to an equal extent at all temperatures tested. We
sought new conditional mutants of Civ1 to see whethertion was abolished by the Cdc28(T169A) mutation (Fig-
ure 5C). Further evidence that this CAK activity is coded temperature-sensitive growth would be correlated with
a temperature-sensitive loss of CAK activity in vivo. Thefor by the CIV1 gene was obtained by showing that a
His6–Civ1(K31A) mutant, purified as for the wild-type CIV1 gene was polymerase chain reaction (PCR) ampli-
fied under mutagenic conditions, and the amplified DNAprotein, had less than 5% the activity of the wild-type
Civ1 in vitro (C. Miled and C. M., unpublished data). This fragments were integrated at the chromosomal CIV1
locus as described in Experimental Procedures. Wemutation affects a highly conserved lysine residue of
the protein kinase family that is involved in binding ATP. screened for mutants that grew well at 248C but not at
378C. We chose the civ1-4 mutant for further analysisThus, monomeric Civ1–His6 appears to be both neces-
sary and sufficient for CAK activity in vitro toward both because it arrested cell division within one cell cycle
after transfer to 378C. Furthermore, we found that civ1-4Cdc28–His6 and GST–Cdk2.
is synthetically lethal at 248C when combined with the
cdc28-1 or cdc28-4 mutants (see Experimental Proce-Cdc28 Activity and Phosphorylation Are
dures). Thus, partial inactivation of Civ1 at the permis-Inhibited In Vivo in the civ1-4 Mutant
sive temperature of 248C is lethal when Cdc28 activityThe preceding results indicated that Civ1 is both neces-
is also reduced by the cdc28-1 or cdc28-4 temperature-sary and sufficient for in vitro CAK activity. We next
sensitive mutations. These genetic interactions suggestsought to determine whether Civ1 is required for CAK
that the two proteins functionally interact.activity in vivo. We found that Cdc28 kinase activity
Flow cytometric analysis showed that 70% of civ1-4and overall phosphorylation of Cdc28 are reduced to
mutant cells arrested division at 378C with a 1N DNA10%–20% of the wild-type levels at 248C, 308C, and 398C
content and 30% with a 2N DNA content (Figure 6B).in the civ1-1 mutant (unpublished data). Thus, the civ1-1
mutation appears to inactivate partially the CAK activity Microscopic analysis revealed that 75% of the civ1-4
Cell
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Figure 4. Coimmunoprecipitation of Cdc28 and Its Activating
Kinase
(A) Civ1 coimmunoprecipitates with Cdc28. Polyclonal antibodies
were used to immunoprecipitate Cdc28 from 13 mg of CMY826
crude extract (lane 2) as described in Experimental Procedures. In
lane 1, only protein A–Sepharose was added to 13 mg of CMY826
crude extract. Coprecipitating Civ1 was detected by submitting the
immunoprecipitates to SDS–PAGE, transferring the proteins to a
membrane, probing the membrane with anti-Civ1 antibodies, and
then developing the blots by enhanced chemiluminescence using
HRP-conjugated anti–rabbit IgG antibody. Lane 3 contains 5% of
an anti-Civ1 immunoprecipitation from 13 mg of a CMY826 extract
to show the migration of the Civ1 protein.
(B) Cdc28 coimmunoprecipitates with Civ1. Anti-Civ1 polyclonal an-
tibodies were used to immunoprecipitate Civ1 from 13 mg of
CMY826 crude extract (lane 3) or 13 mg of CMY826 crude extract
containing 50 mg of denatured Civ1 prepared from E. coli inclusion
bodies as a competitor for the endogenous Civ1 (lane 1). In lane 2,
protein A–Sepharose alone was added to 13 mg of CMY826 crude
extract. Lane 4 contains 5% of an immunoprecipitation of Cdc28
with anti-Cdc28 polyclonal antibodies from 13 mg of CMY826 ex-
tract to show the position of Cdc28. Immunoprecipitated proteins
were electrophoresed on an SDS–10% polyacrylamide gel, trans-
ferred to a membrane, and probed with polyclonal anti-Cdc28 anti-
bodies.
cells arrested division as unbudded cells with a single
nucleus (Figure 6A). The remaining cells were arrested
with elongated buds containing one or two nuclei. These
results show that the civ1-4 allele leads to a predomi-
nantly G1 arrest of cell division at the restrictive temper-
ature, but with a significant fraction of cells arrested
with a 2N content of DNA in G2/M both before and
after chromosome segregation. Thus, like Cdc28, Civ1
Figure 5. Monomeric His6–Civ1 Phosphorylates Monomeric Human
GST–Cdk2
(A) Purification of His6–Civ1 by Ni–NTA–agarose chromatographyE. coli) and analyzed 1 ml of each fraction by SDS–PAGE and silver
after overexpression in yeast. We electrophoresed45 mg of the inputstaining. The His6–Civ1 that eluted from the Superdex 75 column at
protein fraction (clarified cell extract), 45 mg of the flowthrough (FT),fraction 14 had a lower specific activity than the His6–Civ1 in the
7.5 mg of the 20 mM imidazole wash fraction, and 500 ng of the 250peak fractions 12 and 13. Although we have no definitive explanation
mM eluate fraction on an SDS–10% polyacrylamide gel and stainedfor this observation, the fact that this material is found in a more
proteins with Coomassie blue.included fraction of the column (smaller apparent molecular mass)
(B) Highly purified monomeric His6–Civ1 can phosphorylate GST–suggests that a proportion of the His6–Civ1 may be in a less active
Cdk2. His6–Civ1 (48 mg) purified by Ni–NTA–agarose chromatogra-form that influences its migration on this column.
phy was size-fractionated on a Superdex 75 column. The migration(C) The capacity of 0.6 ng of the peak fraction 13 to activate the
of 25, 45, and 67 kDa marker proteins on this column is shown. Wehistone H1 kinase activity of GST–Cdk2, Cdc28–His6, and
assayed 1 ml of a 1:100 dilution of each fraction from the columnCdc28(T169A)–His6 in the presence of cyclin A was assayed as
for its ability to phosphorylate 500 ng of GST–Cdk2 (purified fromdescribed in Experimental Procedures.
In Vivo CAK
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Figure 6. Rapid Arrest of civ1-4 Cell Division at 378C Is Correlated
with a Loss of Cdc28 Phosphorylation and Histone H1 Kinase Ac-
tivity
Rho8 derivatives (lacking mitochondrial DNA) of civ1-4 (GF2351) and
isogenic wild-type cells were grown in yeast extract–peptone–
dextrose (YPD) at 248C, or after transfer to 378C for 5 hr, and then
fixed in 70% ethanol. Cells were then prepared for flow cytometry by
RNase treatment and staining of nuclear DNA with the fluorochrome
propidium iodide as previously described (Mann et al., 1992). A
portion of these samples was used in fluorescence microscopy to
visualize cell and nuclear morphology (A) and a portion was used
for flow cytometric analysis to determine the DNA content in individ-
ual cells. The scale bar in (A) is 13 mm. In (B), the horizontal axes
represent the relative fluorescent intensity and the vertical axes
show cell number. Wild-type cells contained an approximately equal
proportion of cells with a 1N and 2N DNA content at 248C and 378C,
whereas the proportion of cells with a 1N DNA content increased
from 50% to 70% in transferring the civ1-4 mutant from 248C to
378C for 5 hr. Rho8 derivatives lacking mitochondrial DNA were used
for these experiments because the amplification of mitochondrial
DNA in the rho1 civ1-4 cells at 378C was found to obscure the
fluorocytometric analysis of nuclear DNA content. Rho8 derivatives
were induced by ethidium bromide treatment as described pre-
viously (Simon and Faye, 1984).
(C) Histone H1 kinase activity of Cdc28–HA immunoprecipitated
from wild-type and civ1-4 cells. Cdc28–HA was immunoprecipitated
from CMY951 (wild-type CDC28–HA) and CMY979 (civ1-4 CDC28–
HA) cells growing at 248C and after a shift to 378C for 5 hr. The
histone H1 kinase activity of the immunoprecipitatedCdc28–HA was
assayed as described in Experimental Procedures. The parental
wild-type strain (GF312-17C) that contained only untagged Cdc28
was used to control the specificity of the immunoprecipitation.
(D) Phosphorylation of Cdc28 in wild-type and civ1-4 cells. CMY951
(wild-type CDC28–HA) cells (lanes 2 and 4) and CMY947 (civ1-4
CDC28–HA) cells (lanes 3 and 5) were grown in YPD low phosphate
medium at 248C and after transfer to 378C for 5 hr. Cells were then
labeled with [33P]orthophosphate for 1 hr. A wild-type strain that
expresses endogenous untagged Cdc28 and a Cdc28–His6 protein,
but not Cdc28–HA, was also labeled with [33P]orthophosphate at
248C as a specificity control for the immunoprecipitation (lane 1).
Cell extracts were prepared, and Cdc28 proteins were immunopre-
cipitated as described in Experimental Procedures. Immunoprecipi-
tated proteins were solubilized by heating in 50 ml of SDS–PAGE sample buffer. We used 5 ml of each sample for the anti-Cdc28 Western
blot shown in the upper panel to evaluate the quantity of the different Cdc28 forms precipitated and 20 ml for the PhosphorImager analysis
shown in the lower panel.
is required for both the G1/S and G2/M transitions of wild-type strain. A hemagglutinin (HA) epitope sequence
was added to the chromosomal CDC28 gene (see Exper-the yeast cell cycle.
Since Cdc28 must be phosphorylated on Thr-169 to imental Procedures) in the wild-type strain and the
civ1-4 mutant, and Cdc28–HA was immunoprecipitatedbe active (Figure 3B, lanes 2 and 3), we first examined
thehistone H1 kinase activity of Cdc28 after immunopre- from crude protein extracts prepared from cells growing
exponentially at 248C or after 5 hr of incubation at 378C.cipitation from the civ1-4 mutant versus the isogenic
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The parental wild-type strain that expressed untagged on a conserved threonine residue by a distinct kinase
called CAK (Dore´e and Galas, 1994; Morgan, 1995). WeCdc28 was used as a control for the specificity of the
immunoprecipitation. The histone H1 kinase activity as- discovered that a preparation of Cdc28 partially purified
from yeast contained a copurifying CAK activity, whichsociatedwith the immune precipitates was then assayed
(Figure 6C). At 248C, the activity of Cdc28–HA immuno- we identified and named Civ1.
Strikingly, Civ1 most closely resembles the Cdk sub-precipitated from the civ1-4 mutant was 50% that of
Cdc28–HA immunoprecipitated from the isogenic wild- family of protein kinases (Figure 2). However, it has sev-
eral unique features that suggest that it may be thetype strain. After a 5 hr incubation at 378C, thehistone H1
kinase activity of Cdc28–HA immunoprecipitated from founding member of a novel class of protein kinase.
First, unlike the Cdks, monomeric Civ1 is functional asciv1-4 was reduced to 5% the level of the wild type.
Thus, Cdc28 histone H1 kinase activity is greatly de- a kinase (Figure 5). Second, the Civ1 sequence contains
several insertions of 5–29 amino acids between internalcreased in the civ1-4 mutant at its restrictive tempera-
ture. This decrease may be due in part to the increase elements of secondary structure found in the Cdk family
(Figure 2). Finally, Civ1 is entirely lacking the GxGx(Y/from 50% to 70% of G1-phase cells in the civ1-4 popula-
tion upon passage from 248C to 378C (Figure 6B), since F)GxV motif that is found in most other protein kinases
(Bossemeyer, 1994). Vps15, a protein kinase involvedCdc28 activity in the wild type is lower in the G1 phase
compared with the rest of the cell cycle (Surana et al., in intracellular protein sorting in yeast cells, is to our
knowledge the only other protein kinase that also is1991). We thus directly tested whether Cdc28 phosphor-
ylation is affected in vivo in the civ1-4 mutant. totally lacking any glycines in this region (Herman et al.,
1991). However, aside from the absence of this glycine-If Civ1 is the in vivo CAK of Cdc28, a strong prediction
is that inhibition of Cdc28 kinase activity in the civ1-4 rich motif, the two kinases do not share any extended
sequence similarity. The glycine-rich motif is found in amutant should be correlated with a reduction in the
level of Cdc28 phosphorylation on its activating Thr- loop that covers the ATP bound to the kinase active
site. Further structural analysis is required to understand169 residue. Cismowski et al. (1995) have shown that
in exponentially growing wild-type cells the majority of how these kinases manage to function in the absence
of these highly conserved residues.Cdc28 phosphorylation occurs on Thr-169. Further-
more, they have shown that Cdc28 remains phosphory- Civ1 could phosphorylate Cdc28 in the absence of
cyclins, but the phosphorylated Cdc28 was inactive, atlated in vivo even when cyclins are depleted from cells
by shutting down gene transcription with a kin28-ts mu- least with respect to its ability to phosphorylate histone
H1 in vitro. Phosphorylated Cdc28 could be activatedtant. We thus anticipated that if Civ1 was the in vivo
CAK, then the overall levels of [33P]phosphate incorpo- by the addition of a cyclin. Cdc28 phosphorylated on
Thr-169 thus resembles Cdc2 and Cdk2 phosphorylatedrated into Cdc28should be reduced in the civ1-4 mutant.
To test this possibility, we radiolabeled civ1-4 and wild- on Thr-161 and Thr-160, respectively, in having very low
activity in the absence of a cyclin (Poon et al., 1993;type cells expressing Cdc28–HA with [33P]orthophos-
phate after growth at 248C or 378C for 5 hr (Figure 6D). Fisher and Morgan, 1994; Desai et al., 1995). These prop-
erties of Cdc28 and Civ1 can account for the findingAs a specificity control for the immunoprecipitation, we
also labeled wild-type cells expressing both the normal that depletion of cyclins in budding yeast led to inactiva-
tion of Cdc28 without affecting the levels of Cdc28 phos-untagged Cdc28 protein and Cdc28–His6 (Figure 6D,
lane 1). Equal quantities of Cdc28–HA were immunopre- phorylation in vivo (Cismowski et al., 1995).
cipitated from the civ1-4 and wild-type cells labeled with
[33P]phosphate (see Western blot panel of Figure 6D).
Civ1 Is an In Vivo CAK of S. cerevisiaePhosphorImager quantitation revealed that Cdc28–HA
Civ1 interacts strongly with Cdc28, as evidenced byimmunoprecipitated from the civ1-4 mutant at 248C con-
the existence of a Cdc28–Civ1 complex that can betained only 25% the amount of [33P]phosphate associ-
immunoprecipitated from crude protein extracts (Figureated with Cdc28–HA from the wild-type strain at 248C
4). Civ1 thus joins a long list of regulatory proteins that(Figure 6D, lanes 2 and 3). Moreover, upon incubation
have been shown to bind tightly to Cdc28 or the homolo-at378C for 5 hr, no [33P]phosphate above thebackground
gous Cdc2/Cdk2 kinases, including the cyclin family oflevels could be found associated with Cdc28–HA immu-
proteins (Jeffrey et al., 1995), the suc1/Cks1 family (Had-noprecipitated from civ1-4 (Figure 6D, lane 5), whereas
wiger et al., 1989; Ducommun et al., 1991), the KAP/the same incubation stimulated [33P]phosphate incorpo-
Cdi1 phosphatase (Gyuris et al., 1993; Hannon et al.,ration into Cdc28–HA in the wild-type strain. These re-
1994; Poon and Hunter, 1995a), and a series of Cdk-sults show that inactivation of Civ1 is accompanied by
inhibitory proteins (for review see Hunter and Pines,a rapid loss of Cdc28 phosphorylation and activity in
1994). The tight association of Civ1 with Cdc28 arguesvivo. We conclude that Civ1 is the yeast CAK.
strongly for the specificity and the physiological rele-
vance of Cdc28 activation by Civ1.
Further evidence that Civ1 is a CAK in vivo comesDiscussion
from our analysis of the civ1-4 mutant (Figure 6). This
mutant arrests cell division within one cell cycle at 378CCiv1 Is a Novel Type of CAK
Cdc28 is a Cdk that is a key regulator of the cell division with approximately 70% of cells in G1 phase and the
remainder in G2/M. This mixed arrest would be expectedcycle of S. cerevisiae (Nasmyth, 1993). Activation of
Cdc28 and most other Cdks is dependent on the binding if both G1 and G2 forms of Cdc28 require phosphoryla-
tion on Thr-169 for their activity. Indeed, division arrestof a cyclin peptide and phosphorylation of the kinase
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sequences closely related to Cdc28 (SwissProt: CC28_YEAST,is correlated with the near-total loss of Cdc28 phosphor-
CC2_SCHPO, CC2_DICDI, CC2_CAEEL, CC2_CHICK,CC2_DROME,ylation and Cdc28 histone H1 kinase activity. The com-
CC2_HUMAN, CDK2_HUMAN, CDK3_HUMAN) with the ClustalW1.5bined biochemical and genetic characterization of Civ1
program (Thompson et al., 1994). More distantly related Cdks
strongly suggests that it is the physiologically relevant (including the MO15/CDK7 subfamily) were then added to the
CAK for Cdc28. alignment with the same program (SwissProt: CDK4_HUMAN,
CDK5_HUMAN, CDK6_HUMAN, KI28_YEAST; EMBL: X91239/Budding yeast cells contain four other Cdks in addi-
L47353 [CRK1/MOP1], X79193 [human MO15]; PIR: S12091 [Xeno-tion to Cdc28. These are Pho85 (Espinoza et al., 1994;
pus MO15], A56231 [mouse MO15]). Finally, CIV1 was added, andMeasday et al., 1994), Srb10 (Liao et al., 1995), Ctk1
the alignment was completed by visual inspection.(Sterner et al., 1995), and Kin28 (Valay et al., 1993). It is
A civ1::LEU2 disruption was made by replacing an internal EcoRV–
currently not known whether Civ1 can phosphorylate Xcm1 CIV1 fragment with a LEU2 gene fragment. This substitution
and activate these Cdks. Interestingly, CIV1 was first deletes nearly 90% of the CIV1 coding sequence. A civ1::LEU2 DNA
fragment was then used to transform the diploid yeast strainisolated as a dosage-dependent suppressor of kin28-
DG146-1. A civ1::LEU2 transformant of this strain was then sporu-ts mutants and the civ1-1 mutation (originally called
lated, and tetrads were dissected on YPD plates at 248C. No tetradsmca28-782) was isolated in a screen for mutants that
were obtained with more than two viable spores, and all such sporesare synthetically lethal with kin28-ts3 (Valay, 1994; Valay
were auxotrophic for leucine. Microscopic examination of the
et al., 1995). These genetic interactions suggest that civ1::LEU2 spores showed that they had germinated and undergone
Civ1 might be able to phosphorylate and activate Kin28. several divisions before arresting growth in the form of long filamen-
tous cells (see Figure 2B).However, less direct interactions are equally possible.
Mutagenesis of CIV1Is There More than One Class of In Vivo CAK?
The CIV1 gene was amplified by PCR under mutagenic conditionsThe first CAK to be identified was the MO15/cdk7–cyclin
as described previously (Zhou et al., 1991). The amplified CIV1 DNA
H kinase (for review see Solomon, 1994). Homologs of fragments were then integrated into the yeast genome at the CIV1
this kinase have been found from yeast to humans. Sur- locus by transformation of the yeast strain JGV131 and selection
prisingly, this kinase was also found to be an integral for cycloheximide-resistant transformants at 258C as described pre-
viously (Simon et al., 1993). Transformants were then replicated tocomponent of the multisubunit TFIIH transcription factor
plates containing 5-fluoroorotic acid to counterselect the URA3–complex required for basal transcription by RNA poly-
CIV1-containing plasmid, and temperature-sensitive mutants weremerase II (Feaver et al., 1994; Roy et al., 1994; Serizawa
screened for by replicating to 378C. The civ1-4 mutation was com-
et al., 1995; Shiekhattar et al., 1995). Are cdk7–cyclin H plemented by the wild-type CIV1 gene and was genetically linked
homologs required for both Cdk activation and RNA to the CIV1 locus. Details of this screen will be published elsewhere.
polymerase II transcription in vivo? In S. cerevisiae, the
answer is seemingly no. Kin28–Ccl1 is the apparent ho- Synthetic Lethality between civ1-4 and cdc28
Strain GF2351 civ1-4 was crossed to cdc28-1 and cdc28-4 mutants,molog of cdk7–cyclin H in S. cerevisiae, and kin28 mu-
and the heterozygous diploids were sporulated. We dissected 20tants have been shown to inhibit RNA polymerase II
tetrads for each genetic cross and germinated spores on YPD attranscription without affecting Cdc28 phosphorylation
the permissive temperature of 248C for the mutants. For both
(Cismowski et al., 1995; Valay et al., 1995). Consistent crosses, no viable civ1-4 cdc28 double mutant was found. All spores
with these results, we have identified a novel CAK that deduced to have the double-mutant genotype in tetra-type or non-
is required for Cdc28 phosphorylation and activation in parental di-type tetrads were dead, whereas single mutants showed
good colony-forming ability. We conclude that the civ1-4 mutationvivo. Given thehigh degree of conservation of eukaryotic
is synthetically lethal at 248C when combined with either cdc28-1cell cycle regulators, it is possible that Civ1 homologs
or cdc28-4.will be found in other eukaryotes. Interestingly, Cdc2
was phosphorylated in vitro on its activating Thr-161
Cloning of the CDC28 Gene in Expression Vectors
residue after immunoprecipitation from chicken cells, The CDC28 gene was PCR amplified from a CDC28-containing
apparently by a coprecipitating kinase (Krek and Nigg, plasmid with the Pfu DNA polymerase using oligonucleotides
NcoI–CDC28 (59-ATGGCCATGGATATGAGCGGTGAATTAGCA-39)1992). This result recalls our findings with Cdc28 and
and CDC28–XhoI (59-GTGCTCGAGTGATTCTTGGAAGTAGGG-39).Civ1, so it would be useful to identify this kinase. If
The amplified fragment was digested with NcoI and XhoI and clonedCiv1 homologs are found in other eukaryotes in which
into plasmid pEt22b (Novagen). The resulting plasmid, pECNX, al-Cdk7–cyclin H is thought to be the CAK, it will be impor-
lowed overexpression of Cdc28–His6 in a bacterial T7 expressiontant to determine whether there really is more than one system. The absence of PCR-introduced mutations was verified by
class of physiologically relevant CAK. DNA sequencing.
A CDC28–HIS6 NcoI–ScaI fragment derived from pECNX was
cloned into the NcoI and SmaI sites of the 2m plasmid Fusionator-Experimental Procedures
DlacZ. FusionatorDlacZ was made by replacing the lacZ coding
sequence on a NheI–HindIII fragment of theFusionator vector (BarralYeast Strains
The genotypes of strains used in this paper are shown in Table 1. et al., 1995) with a BglII adaptor (NBH2, 59-CTAGCCAGATCTCA-39;
HBN2, 59-AGCTTGAGATCTGG-39). This multicopy LEU2 plasmid,
called pDFM1, can express Cdc28–His6 to high levels in yeast fromCloning, Sequencing, and Disruption of the CIV1 Gene
The CIV1 gene was initially isolated as a multicopy extragenic sup- the GAL10 promoter.
pDFM1 was digested with SalI, the extremities were blunt endedpressor of a kin28-ts mutant (Valay et al., 1993, 1995; Valay, 1994).
The gene was sequenced, and this sequence was later indepen- with T4 DNA polymerase, and the CDC28–HIS6 fragment was cut
with SphI. This fragment was then cloned into the 2m vector pYES2dently determined during the systematic sequencing of yeast chro-
mosome VI (GenBank accession number D50617), where the ORF (Invitrogen) at the HindIII (blunt ended) and SphI sites, and the re-
sulting multicopy plasmid was called pDYM1. pDYM1 carries awas referred to as YFL029C and the corresponding translated pro-
tein sequence was deposited under SwissProt accession number URA3 selectable marker and allows high level expression of Cdc28–
His6 in yeast from the GAL1 promoter. pDYM1 was used for theP43568.
The sequence comparison in Figure 2A was made by first aligning construction of all cdc28 mutants used in this work.
Cell
574
Table 1. Yeast Strains Used in This Study
Yeast Strains Genotypes
DG146-1 MATa/MATa ura3/ura3 trp1/trp1 leu2-3,112/leu2-3,112 lys2/1 his3/1
GF312-17C MATa ura3 leu2 trp1 lys2 ade2 ade3
GF330-1C MATa civ1-lura3 leu2 trp1 lys2 ade2 ade3
GF2351 MATa civ1-4 ura3 leu2 trp1 lys2 ade2 ade3
CMY826 MATa ura3-52 trp1D1 his3D200 leu2D1 lys2-801 ade2-101 bar1::HIS3
YJY88 CMY826/pJG63 (expressing Gal4–Civ1) plus pDYM1-CDC28-HIS6
YJY95 CMY826/pJG63 plus pDYM1-cdc28(T169A)–HIS6
CMY951 GF312-17C URA3::CDC28–HA
CMY979 GF2351 URA3::CDC28–HA
JGV131 MATa ura3 leu2 trp1 lys2 cyh2R civ1::LEU2-TRP1-CYH2S/pJG43-URA3-CIV1
CMY951 and CMY979 were made by transforming strains GF312-17C and GF2351 with KpnI-linearized pRD85 (a generousgift of Ray Deshaies).
Integration of this URA31 plasmid at the CDC28 locus introduces an HA epitope at the carboxyl terminus of Cdc28 (Deshaies and Kirschner,
1995).
Site-Directed Mutagenesis of the CDC28 Gene or, for larger volumes, were submitted to a first centrifugation at
10,000 rpm for 20 min (to remove cell debris) followed by an ultracen-All mutants were constructed using the Stratagene Chameleon Dou-
ble-Stranded Site-Directed Mutagenesis kit following the protocol trifugation at 45,000 rpm for 1 hr to produce an S100. Cdc28–His6
was precipitated from the S100 with ammonium sulfate (50%satura-recommended by the manufacturer. The selection oligonucleotide
was Yes–SalI (59-CCCTCTAGATGTCGACGGATCTCAGTGG-39) and tion), and the pellet was resuspended in N1 buffer before loading
on the Ni–NTA–agarose column, whereas S100 extracts containingthe restriction enzyme used for selection was SphI. The following
oligonucleotides were used to construct the corresponding mutants: His6–Civ1 were directly loaded on the affinity column. Purification
on Ni–NTA–agarose (Quiagen) was performed according to the pro-K40R, 59-CTCTAGTCTTATTTTGCGCAATGCGACTACTC-39; T169A,
59-TAGAGTAACAATTTCATGCGCATAAGCTCTCAACGGAA C-39. tocol of the manufacturer. After loading of the extracts, the column
was washed with at least ten bed volumes of N20 buffer (50 mMThe oligonucleotides created a new restriction site sequence. The
incorporation of the mutation was screened for by assessing the Tris–HCl [pH 7.5], 20 mM imidazole, 10% glycerol). His6–tagged
proteins were then eluted with N250 buffer (50 mM Tris–HCl [pHexistence of the extra site (FspI for K40R and BssHII for T169A).
7.5], 250 mM imidazole, 10% glycerol).
Plasmids Carrying the CIV1 Gene
The CIV1 gene was PCR amplified from a CIV1-containing plasmid Gel Exclusion Chromatography
Partial separation of Cdc28–His6 from endogenous Civ1 in partiallyusing oligonucleotides MCA-59 (59-GAGGAGGAATTCATGAAACTG
GATAGTATAGAC-39) and MCA-39 (59-CAGCTTGGATCCTTATGGCT purified fractions of Cdc28–His6 and size fractionation of His6–Civ1
after Ni–NTA–agarose chromatography were carried out on a Phar-TTTCTAATTCTTGC-39). The PCRfragment was digested with BamHI
and EcoRI and inserted in the plasmid pGBT9 at the corresponding macia Superdex 75 resin using the Pharmacia SMART chromatogra-
phy system. The separation buffer was 50 mM Tris–HCl (pH 7.5),sites, resulting in plasmid pJG63. The functionality of the CIV1 gene
was verified by its ability to suppress kin28-ts mutants. In pJG63, 100 mM ammonium sulfate. We collected 48 fractions of 45 ml.
a Gal4 DNA-binding domain–Civ1 fusion protein is expressed from
the ADHI promoter. Coimmunoprecipitation of Civ1 and Cdc28
Log-phase yeast cells in YPD at 308C were harvested (4 g wetpJG63 was digested with EcoRI and blunt ended with T4 DNA
polymerase, and the CIV1-containing fragment was then cut with weight), washed once with cold water, and resuspended in 4 ml of
cold lysis buffer (25 mM Tris–HCl [pH 7.5], 100 mM NaCl, 0.1% TritonBamHI. This fragment was inserted into plasmid pET14b (Novagen)
at sites NdeI (blunt ended) and BamHI, resulting in plasmid pEt14b- X-100, 5% glycerol, 10 mM EGTA, 10 mM MgCl2, 1 mM dithiothreitol,
1 mM NaN3, 2 mg/ml each of leupeptin, aprotinin, chymostatin,CIV1, which was suitable for overexpression of His6–Civ1 in a bacte-
rial T7 expression system. pepstatin, and 1 mM PMSF). Cells were broken with a French press,
and the extract was centrifuged at 15,000 rpm at 48C for 30 min. TheAn EcoRI–BamHI fragment of pJG63 was subcloned at the corre-
sponding sites into the centromeric plasmid YCpIF16 (Foreman and protein concentration of the extracts was determined by Bradford
assay. Crude extract (13 mg) was incubated for 2 hr at 48C withDavis, 1994). The resulting plasmid was called YCpIF-CIV1 and car-
ried HA–CIV1 under the control of the GAL1 promoter. 50 ml of protein A–Sepharose beads containing covalently coupled
polyclonal anti-Cdc28 or anti-Civ1 antibodies. These antibodiesA fragment carrying HIS6–CIV1 was isolated from pEt14b-CIV1 by
digestion with BamHI and partial digestion with NcoI and cloned in were obtained from rabbits immunized with denatured Cdc28 or
Civ1 proteins purified from E. coli inclusion bodies. Beads were thenFusionatorDlacZ at the NcoI and BamHI sites. The resulting plasmid
was called FUS-HIS6-CIV1 and was used for overexpressing His6– washed twice with lysis buffer and resuspended in 40 ml of sample
buffer. Proteins were denatured by heating at 1008C for 4 min andCiv1 in yeast from the GAL1 promoter.
then separated on SDS–10% polyacrylamide gels. Proteins were
transferred to Immobilon-P membranes (Millipore), and membranesPurification of Cdc28–His6 or His6–Civ1
We grew yeast strains transformed with either pDYM1-CDC28-HIS6 were incubated with either polyclonal antibodies (1:2000 dilution)
directed against the C-terminal ten amino acids of Cdc28 or anti-or FUS-HIS6-CIV1 to log phase in synthetic glucose medium while
maintaining selection for URA3 or LEU2 plasmids at 308C. Cells Civ1 antibodies (1:1000 dilution). Primary antibodies were revealed
by enhanced chemiluminescence (Amersham) using horseradishwere harvested, washed once in water, and then resuspended in
the same volume of YP–2% galactose. Cells were subsequently peroxidase (HRP)-conjugated anti–rabbit IgG.
grown at 308C for 7–15 hr. Cells were then harvested, washed once
in cold N1 buffer (50 mM Tris–HCl [pH 7.5], 1 mM imidazole, 10% Cdc28–His6 and GST–Cdk2 Phosphorylation
and Activation In Vitroglycerol), and resuspended in 1 ml of lysis buffer per gram of wet-
weight cells. The lysis buffer was N1 buffer plus 10 mM b-mercapto- Preparations of wild-type or mutant Cdc28–His6 proteins, partially
purified from yeast by Ni–NTA–agarose chromatography as detailedethanol plus a protease inhibitor cocktail (2 mg/ml each of leupeptin,
aprotinin, chymostatin, and pepstatin plus 1 mM PMSF). Depending above, were tested for their ability to be phosphorylated in vitro by
addition of a reaction buffer consisting of 50 mM Tris–HCl (pH 7.5),on the volume, cells were either broken with a French press (>5 ml)
or lysed by vortexing with an equal volume of glass beads. Lysates 20 mM MgCl2, 10 mM ATP, and 1 mCi of [g-32P]ATP to 1–200 ng of
the protein preparation and incubation for 10 min at 308C. In somewere centrifuged either at 15,000 rpm for 30 min for small volumes
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